People for positive change
Making a difference is a purpose shared among our founding team.
ReadyGo is led by former CEOs of diagnostic companies, all with a rich history in delivering ‘diagnostic firsts’. We are passionate about design and making products that are low-cost, easy to use and deliver reliable results wherever they are needed. We bring products to the world that will make a positive difference.
Ben Cobb
Founder / CEO
Ben has spent his entire career innovating new diagnostic products and has founded several public and private start-ups. Some of his products have now become embedded into routine clinical practice, including Genedrive® which was arguably the world’s first true point-of-care molecular platform and is providing a new standard of NHS care. As CEO, Ben has responsibility for overseeing ReadyGo’s day-to-day operations, delivery of its strategy and new product innovation.
Elaine Warburton
Non-Exec Chair / Co-Founder
Elaine is an entrepreneur and seasoned Board director with over 30 years’ healthcare and life sciences experience. She has previously run hospitals, introducing numerous novel devices and services into mainstream medicine. More recently, Elaine was founding CEO of QuantuMDx Group, developers of Q-POC™ – a highly multiplexed, portable point-of-need molecular diagnostic device. Elaine provides governance and commercial oversight to ReadyGo’s Board.
Ben Reed
Chief Commercial Officer
Ben has over 20 years’ experience in the Life Sciences, Contract Research Services and the diagnostic industry, focusing on protein marker detection and molecular biology products and services. Ben has held previous commercial roles at senior and Director level with Ciphergen, Oxford Therapeutics, Primerdesign and Epistem. Ben has a PhD in biochemistry from La Trobe University in Melbourne, Australia.
John Clarkson
Non-Exec Director
John has over 30 years’ experience of developing commercial diagnostics and life science tools. He has held a number of senior commercial and technical leadership positions within both public and private companies, most notably with point-of-care diagnostic device developer Binx Health. In this role, he took the Binx Io® multiplexed molecular diagnostic platform from ideation to commercialisation, first as CEO and latterly as Executive Chair. John provides legal and regulatory oversight to ReadyGo’s Board.
Get in touch
Sign up for ReadyGo™ articles and news
Your details will be stored safely in our database.
We will only be used to send you ReadyGo communications.
You can read more on this in our Privacy Policy.